uniQure NV (QURE)
4.71
+0.03
(+0.64%)
USD |
NASDAQ |
Apr 18, 16:00
4.71
0.00 (0.00%)
After-Hours: 20:00
uniQure Cash from Operations (TTM): -145.93M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -145.93M |
September 30, 2023 | -151.07M |
June 30, 2023 | -238.97M |
March 31, 2023 | -197.65M |
December 31, 2022 | -145.06M |
September 30, 2022 | -137.47M |
June 30, 2022 | -128.64M |
March 31, 2022 | 303.52M |
December 31, 2021 | 287.96M |
September 30, 2021 | 297.87M |
June 30, 2021 | 303.32M |
March 31, 2021 | -143.15M |
December 31, 2020 | -134.83M |
September 30, 2020 | -123.66M |
June 30, 2020 | -110.97M |
March 31, 2020 | -105.20M |
December 31, 2019 | -98.68M |
September 30, 2019 | -90.68M |
June 30, 2019 | -88.72M |
March 31, 2019 | -81.04M |
December 31, 2018 | -76.04M |
Date | Value |
---|---|
September 30, 2018 | -76.08M |
June 30, 2018 | -71.44M |
March 31, 2018 | -74.04M |
December 31, 2017 | -64.27M |
September 30, 2017 | -61.90M |
June 30, 2017 | -64.52M |
March 31, 2017 | -68.13M |
December 31, 2016 | -72.19M |
September 30, 2016 | -81.11M |
June 30, 2016 | -62.04M |
March 31, 2016 | 4.786M |
December 31, 2015 | 7.468M |
September 30, 2015 | 16.68M |
June 30, 2015 | 6.693M |
March 31, 2015 | -42.92M |
December 31, 2014 | -36.85M |
September 30, 2014 | -29.41M |
June 30, 2014 | -6.750M |
March 31, 2014 | -7.806M |
December 31, 2013 | -5.711M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-238.97M
Minimum
Jun 2023
303.52M
Maximum
Mar 2022
-44.63M
Average
-123.66M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
ProQR Therapeutics NV | 23.33M |
Merus NV | -142.21M |
argenx SE | -- |
Pharming Group | -17.30M |
Pharvaris NV | -100.74M |